Divarasib plus cetuximab is well tolerated in patients with KRAS G12C-positive colorectal cancer.
Cancer Res (2022) 82 (12_Supplement): 5462.
1Division of General Internal Medicine, Department of Medicine, Weill Cornell Medicine, New York, New York. 2Division of Epidemiology, Department of Population Health Science, Weill Cornell Medicine, ...
2Department of Medical Oncology, Hôpital Européen Georges Pompidou, Institut du Cancer Paris CARPEM, APHP, Université Paris Cité, Paris, France.
Introduction: Fibrolamellar hepatocellular carcinoma (FLC) is a liver cancer affecting adolescents and young adults without underlying liver disease. Patients with FLC are often diagnosed with ...
1AI For Good, MIcrosoft Research Lab, Redmond, California.
1Radiation Epidemiology Branch, Division of Cancer Epidemiology and Genetics, NCI, NIH, Bethesda, Maryland. *Corresponding Author: Cari M. Kitahara, Division of ...
1Laboratory of Rare Human Circulating Cells (LCCRH), University Medical Centre of Montpellier, Montpellier, France.
1Yonsei University, College of Medicine, Seoul, Republic of Korea.
1Department of Oncology, University of Lausanne, Lausanne, Switzerland.
In 1978, a Cancer Research article by Dougherty and colleagues reported the first large-scale clinical trial of photodynamic therapy (PDT) for treatment of 113 cutaneous or subcutaneous lesions ...
Cancer Res (2023) 83 (8_Supplement): LB031.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback